StockNews.com Initiates Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)
Analysts at StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ:GLMD opened at $1.68 on Friday. The company’s fifty day moving average is $2.40 and […]
Analysts at StockNews.com began coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Get Free Report) in a note issued to investors on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ:GLMD opened at $1.68 on Friday. The company’s fifty day moving average is $2.40 and […]
